Cargando…
High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
The discovery of new therapeutic options against Trypanosoma cruzi, the causative agent of Chagas disease, stands as a fundamental need. Currently, there are only two drugs available to treat this neglected disease, which represents a major public health problem in Latin America. Both available ther...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256210/ https://www.ncbi.nlm.nih.gov/pubmed/25474364 http://dx.doi.org/10.1371/journal.pntd.0003259 |